Insider: Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER - Enliven Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,123 | 931,688 | 933,811 |
| Value | $39,424.11 | $17,301,446.16 | $17,340,870.27 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/23/2025 | DDS | 1,500 | Indirect | COM | $20.03 | $30,045.00 | 931,688 |
| 09/19/2025 | DDS | 4,870 | Indirect | COM | $19.11 | $93,063.27 | 935,318 |
| 09/19/2025 | DDS | 2,130 | Indirect | COM | $20.02 | $42,634.08 | 933,188 |
| 08/21/2025 | DDS | 7,500 | Indirect | COM | $20.01 | $150,099.00 | 940,188 |
| 08/19/2025 | DDS | 5,000 | Indirect | COM | $19.62 | $98,117.50 | 947,688 |
| 07/21/2025 | DDS | 11,924 | Indirect | COM | $22.26 | $265,458.05 | 953,264 |
| 07/21/2025 | DDS | 576 | Indirect | COM | $22.90 | $13,187.75 | 952,688 |
| 06/20/2025 | DDS | 12,500 | Indirect | COM | $21.40 | $267,457.50 | 965,188 |
| 06/03/2025 | DDS | 7,500 | Indirect | COM | $20.03 | $150,219.75 | 977,688 |
| 05/19/2025 | DDS | 5,000 | Indirect | COM | $16.31 | $81,533.50 | 985,188 |
| 05/02/2025 | DDS | 2,470 | Indirect | COM | $20.01 | $49,424.45 | 990,188 |
| 05/01/2025 | DDS | 5,030 | Indirect | COM | $20.07 | $100,966.18 | 992,658 |
| 04/21/2025 | DDS | 4,670 | Indirect | COM | $16.03 | $74,847.96 | 998,018 |
| 04/21/2025 | DDS | 330 | Indirect | COM | $16.72 | $5,517.86 | 997,688 |
| 03/19/2025 | DDS | 12,500 | Indirect | COM | $20.61 | $257,575.00 | 1,002,688 |
| 10/18/2024 | DDS | 847 | Indirect | COM | $30.00 | $25,412.54 | 1,015,188 |
| 10/09/2024 | DDS | 34,289 | Indirect | COM | $28.12 | $964,203.25 | 1,019,624 |
| 10/09/2024 | DDS | 3,589 | Indirect | COM | $28.52 | $102,357.92 | 1,016,035 |
| 10/08/2024 | DDS | 100 | Indirect | COM | $28.51 | $2,851.00 | 1,053,913 |
| 10/08/2024 | DDS | 13,167 | Indirect | COM | $27.96 | $368,173.02 | 1,054,013 |
| 10/01/2024 | DDS | 527 | Indirect | COM | $27.54 | $14,512.10 | 1,077,409 |
| 08/29/2024 | DDS | 11,950 | Indirect | COM | $22.48 | $268,687.39 | 1,077,986 |
| 08/29/2024 | DDS | 50 | Indirect | COM | $23.08 | $1,154.00 | 1,077,936 |
| 07/31/2024 | DDS | 3,099 | Indirect | COM | $27.56 | $85,399.45 | 1,089,936 |
| 07/29/2024 | DDS | 11,797 | Indirect | COM | $26.69 | $314,808.84 | 1,093,238 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research